Medicare Enrolled
Dr. Stephen Martin, M.D.
Gastroenterology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. Stephen Martin is a gastroenterology specialist in Cincinnati, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martin performed 7,886 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Martin received a total of $6,554 from 33 pharmaceutical and/or device companies across 466 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in OH
$6,554 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,886
Medicare services
Top 2% in OH for gastroenterology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Vedolizumab infusion (Entyvio) This procedure involves the administration of vedolizumab via injection. The dosage is measured in milligrams. |
7,200 | $17 | $51 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
145 | $201 | $1,378 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
131 | $86 | $333 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
50 | $66 | $1,138 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $100 | $455 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
45 | $38 | $131 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $61 | $237 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
43 | $101 | $3,000 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
35 | $176 | $1,054 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
28 | $89 | $1,472 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
24 | $47 | $215 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $134 | $670 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
19 | $84 | $917 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
19 | $124 | $1,457 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $50 | $237 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
17 | $176 | $1,075 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
91.6% high complexity
2.1% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,554
Total received (2018-2024)
Avg $936/year across 7 years
Top 28% in OH for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
466
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,882
2023
$1,551
2022
$1,314
2021
$650
2020
$155
2019
$466
2018
$536
Payments by company (2024)
ABBVIE INC.
$818
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$211
Takeda Pharmaceuticals U.S.A., Inc.
$168
Celgene Corporation
$100
QOL Medical, LLC
$89
Gilead Sciences, Inc.
$89
IRONWOOD PHARMACEUTICALS, INC
$76
Janssen Biotech, Inc.
$75
Regeneron Healthcare Solutions, Inc.
$74
Phathom Pharmaceuticals, Inc.
$73
GENZYME CORPORATION
$42
Celltrion USA Inc.
$34
Lilly USA, LLC
$19
AIMMUNE THERAPEUTICS, INC.
$14
Top 3 companies account for 63.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,861
Takeda Pharmaceuticals U.S.A., Inc.
$781
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$643
Janssen Biotech, Inc.
$442
AbbVie, Inc.
$355
AbbVie Inc.
$260
Gilead Sciences, Inc.
$239
QOL Medical, LLC
$227
Celgene Corporation
$219
GENZYME CORPORATION
$197
Ironwood Pharmaceuticals, Inc
$192
PFIZER INC.
$169
Regeneron Healthcare Solutions, Inc.
$144
IRONWOOD PHARMACEUTICALS, INC
$114
Ferring Pharmaceuticals Inc.
$90
Phathom Pharmaceuticals, Inc.
$73
Allergan Inc.
$58
Shionogi Inc
$58
Nestle HealthCare Nutrition Inc.
$51
Daiichi Sankyo Inc.
$45
Merck Sharp & Dohme LLC
$44
Shire North American Group Inc
$39
NESTLE HEALTHCARE NUTRITION INC.
$35
Celltrion USA Inc.
$34
RedHill Biopharma Inc.
$34
Merck Sharp & Dohme Corporation
$31
UCB, Inc.
$27
Lilly USA, LLC
$19
Amgen Inc.
$17
AIMMUNE THERAPEUTICS, INC.
$14
Synergy Pharmaceuticals Inc
$14
AstraZeneca Pharmaceuticals LP
$13
Braintree Laboratories, Inc.
$11
Top 3 companies account for 50.1% of all-time payments
Associated products mentioned in payments ›
AVSOLA · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Entyvio · GATTEX · HUMIRA · Humira · INJECTAFER · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVANTIK · Movantik · Mulpleta · OMVOH · REBYOTA · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
119
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY OF CINCINNATI MEDICAL CENTER, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martin is a mixed practice specialist, with above-average Medicare volume (top 2% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Martin performed 7,200 vedolizumab infusion (entyvio) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $6,554 from 33 companies across 466 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other gastroenterologists in Cincinnati?
Dr. Martin's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Cincinnati
Browse gastroenterologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in OH
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in OH
Which OH gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology